“Substance+dependence”的搜索结果，显示 81-90 项，共有 3183 项

1. 精神分裂症- 诊断与治疗- 妙佑医疗国际

   For friends and family members. Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/mental-health/how-to-talk/friends-and ...

2. 尼古丁依赖中心- 申请预约- 妙佑医疗国际

   Mayo Clinic 与数百家保险公司合作，为数百万人提供网络内服务。在大多数情况下，Mayo Clinic 不需要医师转诊。某些保险要求转诊，或有其它特定医疗方面的要求。

3. 尼古丁依赖症- 诊断与治疗- 妙佑医疗国际

   DrugFacts: Cigarettes and other tobacco products. National Institute on Drug Abuse. https://www.drugabuse.gov/publications/drugfacts/cigarettes-other ...

4. Chemotherapy for prostate cancer - 妙佑医疗国际

   For symptom relief. Mitoxantrone is a chemotherapy drug approved for the relief of symptoms associated with metastatic prostate cancer. It can provide symptom ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of a ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of a ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of a ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of a ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of a ...

10. 乳腺专科门诊- 临床试验- 妙佑医疗国际

    This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...